Literature DB >> 23650262

Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer.

Yanying Huo1, Hong Cai, Irina Teplova, Christian Bowman-Colin, Guanghua Chen, Sandy Price, Nicola Barnard, Shridar Ganesan, Vassiliki Karantza, Eileen White, Bing Xia.   

Abstract

Hereditary breast cancers stem from germline mutations in susceptibility genes such as BRCA1, BRCA2, and PALB2, whose products function in the DNA damage response and redox regulation. Autophagy is an intracellular waste disposal and stress mitigation mechanism important for alleviating oxidative stress and DNA damage response activation; it can either suppress or promote cancer, but its role in breast cancer is unknown. Here, we show that similar to Brca1 and Brca2, ablation of Palb2 in the mouse mammary gland resulted in tumor development with long latency, and the tumors harbored mutations in Trp53. Interestingly, impaired autophagy, due to monoallelic loss of the essential autophagy gene Becn1, reduced Palb2-associated mammary tumorigenesis in a Trp53-wild-type but not conditionally null background. These results indicate that, in the face of DNA damage and oxidative stress elicited by PALB2 loss, p53 is a barrier to cancer development, whereas autophagy facilitates cell survival and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23650262      PMCID: PMC3740014          DOI: 10.1158/2159-8290.CD-13-0011

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  48 in total

1.  Mitochondrial dysfunction in ataxia-telangiectasia.

Authors:  Yasmine A Valentin-Vega; Kirsteen H Maclean; Jacqueline Tait-Mulder; Sandra Milasta; Meredith Steeves; Frank C Dorsey; John L Cleveland; Douglas R Green; Michael B Kastan
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

2.  TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.

Authors:  M S Greenblatt; P O Chappuis; J P Bond; N Hamel; W D Foulkes
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

Review 3.  Deconvoluting the context-dependent role for autophagy in cancer.

Authors:  Eileen White
Journal:  Nat Rev Cancer       Date:  2012-04-26       Impact factor: 60.716

4.  Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.

Authors:  Christian Bowman-Colin; Bing Xia; Samuel Bunting; Christiaan Klijn; Rinske Drost; Peter Bouwman; Laura Fineman; Xixi Chen; Aedin C Culhane; Hong Cai; Scott J Rodig; Roderick T Bronson; Jos Jonkers; Andre Nussenzweig; Chryssa Kanellopoulou; David M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-08       Impact factor: 11.205

5.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

Authors:  J Jonkers; R Meuwissen; H van der Gulden; H Peterse; M van der Valk; A Berns
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

Review 6.  BRCA1 and BRCA2: different roles in a common pathway of genome protection.

Authors:  Rohini Roy; Jarin Chun; Simon N Powell
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

7.  Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice.

Authors:  T Ludwig; P Fisher; V Murty; A Efstratiadis
Journal:  Oncogene       Date:  2001-07-05       Impact factor: 9.867

8.  Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor.

Authors:  Zhenyu Yue; Shengkan Jin; Chingwen Yang; Arnold J Levine; Nathaniel Heintz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

9.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

Authors:  Xueping Qu; Jie Yu; Govind Bhagat; Norihiko Furuya; Hanina Hibshoosh; Andrea Troxel; Jeffrey Rosen; Eeva-Liisa Eskelinen; Noboru Mizushima; Yoshinori Ohsumi; Giorgio Cattoretti; Beth Levine
Journal:  J Clin Invest       Date:  2003-11-24       Impact factor: 14.808

10.  Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.

Authors:  Alison M Y Cheung; Andrew Elia; Ming-Sound Tsao; Susan Done; Kay-Uwe Wagner; Lothar Hennighausen; Razqallah Hakem; Tak W Mak
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

View more
  70 in total

Review 1.  Autophagy, Metabolism, and Cancer.

Authors:  Eileen White; Janice M Mehnert; Chang S Chan
Journal:  Clin Cancer Res       Date:  2015-11-15       Impact factor: 12.531

2.  Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms.

Authors:  Annan Yang; Grit Herter-Sprie; Haikuo Zhang; Elaine Y Lin; Douglas Biancur; Xiaoxu Wang; Jiehui Deng; Josephine Hai; Shenghong Yang; Kwok-Kin Wong; Alec C Kimmelman
Journal:  Cancer Discov       Date:  2018-01-09       Impact factor: 39.397

Review 3.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

Authors:  Rohit Prakash; Yu Zhang; Weiran Feng; Maria Jasin
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

4.  Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors.

Authors:  Anne M Strohecker; Jessie Yanxiang Guo; Gizem Karsli-Uzunbas; Sandy M Price; Guanghua Jim Chen; Robin Mathew; Martin McMahon; Eileen White
Journal:  Cancer Discov       Date:  2013-08-21       Impact factor: 39.397

5.  Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.

Authors:  Christian Bowman-Colin; Bing Xia; Samuel Bunting; Christiaan Klijn; Rinske Drost; Peter Bouwman; Laura Fineman; Xixi Chen; Aedin C Culhane; Hong Cai; Scott J Rodig; Roderick T Bronson; Jos Jonkers; Andre Nussenzweig; Chryssa Kanellopoulou; David M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-08       Impact factor: 11.205

Review 6.  Autophagy in cellular metabolism and cancer.

Authors:  Xuejun Jiang; Michael Overholtzer; Craig B Thompson
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

Review 7.  Targeting autophagy in breast cancer.

Authors:  Paola Maycotte; Andrew Thorburn
Journal:  World J Clin Oncol       Date:  2014-08-10

Review 8.  Targeting autophagy in cancer.

Authors:  Jean M Mulcahy Levy; Christina G Towers; Andrew Thorburn
Journal:  Nat Rev Cancer       Date:  2017-07-28       Impact factor: 60.716

Review 9.  Targeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancers.

Authors:  Anne M Strohecker; Eileen White
Journal:  Cancer Discov       Date:  2014-05-23       Impact factor: 39.397

Review 10.  Functional assays for analysis of variants of uncertain significance in BRCA2.

Authors:  Lucia Guidugli; Aura Carreira; Sandrine M Caputo; Asa Ehlen; Alvaro Galli; Alvaro N A Monteiro; Susan L Neuhausen; Thomas V O Hansen; Fergus J Couch; Maaike P G Vreeswijk
Journal:  Hum Mutat       Date:  2013-12-03       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.